The fully automated Vivostat® System prepares 5-6 ml of autologous fibrin sealant from 120 ml of the patient’s own blood in approx. 24 minutes.

Compared to conventional sealant products, Vivostat® Fibrin offers a multitude of benefits to both the patient and the surgeon:

Excellent safety profile and high biocompatibility

Vivostat® Fibrin is derived from the patient’s own blood and as such it demonstrates excellent biocompatibility. Unlike conventional products, which are most often based on single donor blood, pooled blood or bovine components (e.g. aprotinin), Vivostat® Fibrin does not contain any exogenous thrombin or bovine components. The autologous nature of Vivostat® efficiently eliminates the risks of bovine or human borne contaminants. This is the only way to protect the patient against viral diseases not yet identified.

Unique and versatile application devices

The wide selection of application devices provide the surgeon with unparalleled freedom in the use of fibrin sealant throughout surgery. The application devices can be used intermittently during the entire surgical procedure without experiencing the blockage that is common in conventional systems. Furthermore, Vivostat® Fibrin can be applied at very close range allowing for pinpoint application, and rapid polymerisation ensures that the fibrin remains where it is applied. For more information click here

Superior physical properties

Clinical studies and comparative tests have demonstrated that Vivostat® Fibrin is superior to conventional fibrin sealants on important parameters such as time to haemostasis, elasticity, adhesion to tissue and impact on tissue. For more information click here